Sixty million people in sub-Saharan Africa live at risk of African sleeping sickness, a disease caused by parasites transmitted through the tsetse fly. In the late stage of the disease, when the parasite crosses the blood-brain barrier, the results are oftentimes fatal.
BYU chemistry professor Ken Christensen, students and collaborators at Clemson University have developed an innovative technique using biosensors to monitor the glucose level of Trypanasoma brucei parasites, which could in turn help develop treatments for the sleeping sickness.
“The unique thing about the T. brucei parasite is that it relies on host glucose for survival,” said Christensen, whose study was recently published in top-ranked journal PLOS Neglected Tropical Diseases. “We know that if you could deprive the parasites in the blood stream of glucose, the parasite will die.”
For the study, Christensen tested glucose levels to monitor the metabolism of the parasites using a genetically-encoded glucose biosensor. The biosensor combines three proteins: a cyan florescent protein, a glucose-binding protein, and a yellow florescent protein.
When the glucose-binding protein interacts with glucose in the parasite, the two fluorescent proteins move closer together. Christensen then uses the spectroscopic changes to monitor the fluorescence-intensity ratio between the yellow and cyan proteins. When the proteins are far apart, the blue light from the cyan fluorescent protein remains. But as the proteins move closer together, the blue light goes down and the yellow light from the yellow fluorescent protein increases.
This ratio is proportional to the glucose level in the parasite.
The results obtained from the biosensor provide new insights into the process through which parasites acquire and transport glucose for survival and provide a means to identify molecules that disrupt glucose levels in the parasite.
“In the long run, we hope that some of the glucose-disrupting molecules we are now identifying can be developed into therapeutics to treat African sleeping sickness,” Christensen said.
Learn more: Stopping a tiny — and deadly — fly in its tracks
The Latest on: Sleeping sickness
[google_news title=”” keyword=”sleeping sickness” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sleeping sickness
- The Reason Why Kidney Diseases And Kidney Failures Are More Common In Black Sub-Saharan Africanson April 27, 2024 at 4:36 am
WHY KIDNEY DISEASES ARE MORE COMMON IN BLACKS Compared to the white population, blacks are more than 3 times as likely to have kidney failure .
- Seven Animal Diseases That Are a Threat to Public Healthon April 26, 2024 at 7:10 am
Veterinary doctors, also known as Veterinarians or Veterinary surgeons are trained to detect, diagnose, treat, prevent and control diseases in animals. In so doing, they have a duty to prevent the ...
- Research brief: Silencing sleeping sicknesson April 21, 2024 at 5:00 pm
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
- “The Spiderwick Chronicles ”showrunner weighs in on that 'tense' season finale cliffhangeron April 21, 2024 at 6:00 am
Aron Eli Coleite tells "Entertainment Weekly" about his plans for a second season, which would follow "our version of a prison escape story."Warning: this story contains spoilers for The Spiderwick ...
- ERC Advanced Grant: 2.5 Million Euros for Isabel Rodition April 18, 2024 at 12:25 am
Professor Isabel Roditi has been awarded an ERC Advanced Grant to further strengthen her outstanding research into the pathogen that causes sleeping ...
- Is this the cure for 'sleeping sickness'?on April 17, 2024 at 5:00 pm
For the narcoleptic, the lack of orexin condemns them to regular sleeping bouts, at times of the day when the rest of us are very much awake. For people like 26-year old Gaynor Carr, who lives in ...
- PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sicknesson April 16, 2024 at 9:30 am
Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug market for affected nations As previously ...
- Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallieson April 12, 2024 at 5:02 am
PaxMedica plans to fund a global supply chain for PAX-101 and further advance research and trials for Autism Spectrum Disorder. A successful review and approval of the NDA could further qualify ...
- Medicine: Sleeping Sickness Heroeson February 26, 2024 at 4:52 pm
Raymond Alexander Kelser, Army Medical School bacteriologist, reportedrecently in Science that the yellow fever mosquito apparently transmitshuman sleeping sickness to rabbits. Last week his ...
via Bing News